SELF-STOMA: Effectiveness of Remote Self-care Education for Ostomy Patients

Sponsor
University of Rome Tor Vergata (Other)
Overall Status
Recruiting
CT.gov ID
NCT05796544
Collaborator
(none)
556
5
2
34
111.2
3.3

Study Details

Study Description

Brief Summary

The primary aim of this study is to evaluate whether remote education is as effective as in-person education in improving self-care behaviors of ostomy patients.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Remote self-care education
  • Behavioral: In-person self-care education
N/A

Detailed Description

After signing the informed consent form, patients with ostomy will be assigned to the intervention or active control group (1:1). The intervention group will receive a total of four remote educational sessions over 2 months. The control group will receive the standard care, consisting of in-person standard education.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
556 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Investigator, Outcomes Assessor)
Primary Purpose:
Supportive Care
Official Title:
Telehealth vs In-person Education for Enhancing Self-care of Ostomy Patients (SELF-STOMA): Study Design of a Non-inferiority, Randomized Controlled Trial
Actual Study Start Date :
Jun 1, 2022
Anticipated Primary Completion Date :
Dec 1, 2024
Anticipated Study Completion Date :
Apr 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention Group

The intervention group will receive a total of four remote educational sessions over 2 months.

Behavioral: Remote self-care education
The intervention group will receive a total of four remote educational sessions over 2 months.

Active Comparator: Control group

The control group will receive the standard care, consisting of in-person standard education.

Behavioral: In-person self-care education
The active comparator group will receive a total of four in-person educational sessions over 2 months.

Outcome Measures

Primary Outcome Measures

  1. Self-care maintenance [1 month after the last intervention]

    Self-care maintenance will be measured with the Ostomy Self-care Index (OSCI). Scores range from 0 to 100, with higher scores indicating better self-care maintenance

Secondary Outcome Measures

  1. Self-care monitoring [1 month after the last intervention]

    Self-care monitoring will be measured with the Ostomy Self-care Index (OSCI). Scores range from 0 to 100, with higher scores indicating better self-care monitoring

  2. Self-care management [1 month after the last intervention]

    Self-care management will be measured with the Ostomy Self-care Index (OSCI). Scores range from 0 to 100, with higher scores indicating better self-care management

  3. Self-care self-efficacy [1 month after the last intervention]

    Self-care self-efficacy will be measured with the Ostomy Self-care Index (OSCI). Scores range from 0 to 100, with higher scores indicating better self-care self-efficacy

  4. Stoma-specific quality of life [1 month after the last intervention]

    Stoma-specific quality of life will be measured with the Stoma Specific Quality of Life Index- Scores on this scale range from 20 to 80, with higher scores meaning higher quality of life

  5. Depression [1 month after the last intervention]

    Depression will be measured with the Patient Health Questionnaire 9 (PHQ-9). Scores on this scale range from 0 to 27, with higher scores indicating higher depression

  6. Adjustment to the stoma [1 month after the last intervention]

    Adjustment to the stoma will be measured with the Stoma Adjustment Inventory-23. scores on this scale range from 0 to 92, with higher scores meaning better adjustment

  7. Stomal and peristomal complications rates [1 month after the last intervention]

    Stomal and peristomal complications rates will be collected with a questionnaire developed by the research team.

  8. Health care service utilization [1 month after the last intervention]

    Health care service utilization will be collected with a questionnaire developed by the research team.

  9. Mobility (distance in km from the patient house to the hospital and vice versa, means of transportation used, and presence of a companion) [1 month after the last intervention]

    Mobility will be collected with a questionnaire developed by the research team.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 120 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. having undergone a surgical operation with subsequent ostomy placement;

  2. being at least 18 years old of age;

  3. absence of cognitive decline,

  4. absence of any

  5. being able to manage the software on the smartphone

  6. be willing to participate to the trial and sign the informed consent form.

Exclusion Criteria:
  1. presence of a cognitive decline, assessed with a score > 4 at the Six-item Screener

  2. presence of any stomal or peristomal complication

  3. not being able to read and speak Italian language

Contacts and Locations

Locations

Site City State Country Postal Code
1 Ambulatorio infermieristico per pazienti stomizzati ASL Roma2 S.Eugenio Pertini Roma Rome Italy 00144
2 Azienda SS. Antonio e Biagio e Cesare Arrigo - Alessandria Italy 15121
3 Istituto Tumori Pascale Napoli Napoli Italy 80131
4 Arcispedale S. Maria Nuova Azienda ospedaliera di Reggio Emilia Reggio Emilia Italy 42123
5 Tor Vergata Hospital Roma Italy 00133

Sponsors and Collaborators

  • University of Rome Tor Vergata

Investigators

  • Principal Investigator: Ercole Vellone, Professor, Department of Biomedicine and Prevention

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Ercole Vellone, Associate Professor, University of Rome Tor Vergata
ClinicalTrials.gov Identifier:
NCT05796544
Other Study ID Numbers:
  • N.119.22
First Posted:
Apr 3, 2023
Last Update Posted:
Apr 5, 2023
Last Verified:
Apr 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Ercole Vellone, Associate Professor, University of Rome Tor Vergata

Study Results

No Results Posted as of Apr 5, 2023